Myozyme | Treatment for Pompe Disease | |
H2 tags : Important Safety Information |
Last Update : | 04/December/2011 |
Google PR : | 4 |
Indexed pages : | 52 |
Internal links : | 17 |
External links : | 2 |
Archive : | Check how did the site look in the past? |
Human-Computer Interaction Resource Network
Myozyme | Treatment for Pompe Disease | |
H2 tags : Important Safety Information |
Last Update : | 04/December/2011 |
Google PR : | 4 |
Indexed pages : | 52 |
Internal links : | 17 |
External links : | 2 |
Archive : | Check how did the site look in the past? |
Keyword | Occurrences | Percentage |
---|---|---|
patients | 36 | 2.46% |
myozyme | 36 | 2.46% |
reactions | 35 | 2.39% |
cardiac | 19 | 1.30% |
infusion | 18 | 1.23% |
Keyword | Occurrences | Percentage |
---|---|---|
patients with | 14 | 1.91% |
pompe disease | 13 | 1.78% |
should be | 10 | 1.37% |
infusion reactions | 10 | 1.37% |
with myozyme | 9 | 1.23% |
Keyword | Occurrences | Percentage |
---|---|---|
onset pompe disease | 6 | 1.23% |
in patients with | 6 | 1.23% |
infantile onset pompe | 6 | 1.23% |
cardiac or respiratory | 5 | 1.02% |
in clinical studies | 5 | 1.02% |
Site IP address : | 164.109.59.74 |
Server type : | Microsoft-IIS/6.0 |
Powered by : | ASP.NET |
Alexa rank : | 8,219,240 |
Description : |
myozyme | 77.37% |
myozye | 6.24% |
antibody increased during allergic reactions | 5.60% |
pompe disease treatment | 5.32% |
myozyk | 4.61% |
acute cardiorespiratory failure | 0.64% |
genzyme | 0.21% |
Quantcast rank : | 0 | Average US daily traffic : |
Compete rank : | 0 |
Average daily unique visitors : | 0 |
MyWot rank : | 0 |
Trustworthiness : | 75 |
Vendor reliability : | 0 |
Privacy : | 0 |
Child safety : | 0 |